GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LipoScience Inc (FRA:LI0) » Definitions » Price-to-Owner-Earnings

LipoScience (FRA:LI0) Price-to-Owner-Earnings : (As of May. 19, 2024)


View and export this data going back to . Start your Free Trial

What is LipoScience Price-to-Owner-Earnings?

As of today (2024-05-19), LipoScience's share price is €2.32. LipoScience does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for LipoScience's Price-to-Owner-Earnings or its related term are showing as below:


FRA:LI0's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.85
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-19), LipoScience's share price is €2.32. LipoScience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2014 was €-0.64. Therefore, LipoScience's PE Ratio for today is At Loss.

As of today (2024-05-19), LipoScience's share price is €2.32. LipoScience's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.63. Therefore, LipoScience's PE Ratio without NRI for today is At Loss.


LipoScience Price-to-Owner-Earnings Historical Data

The historical data trend for LipoScience's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LipoScience Price-to-Owner-Earnings Chart

LipoScience Annual Data
Trend Dec10 Dec11 Dec12 Dec13
Price-to-Owner-Earnings
- - - -

LipoScience Quarterly Data
Mar11 Jun11 Dec11 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of LipoScience's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, LipoScience's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LipoScience's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LipoScience's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LipoScience's Price-to-Owner-Earnings falls into.



LipoScience Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LipoScience's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.32/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LipoScience  (FRA:LI0) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


LipoScience Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of LipoScience's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


LipoScience (FRA:LI0) Business Description

Traded in Other Exchanges
N/A
Address
LipoScience Inc was incorporated under the laws of North Carolina in June 1994 under the name LipoMed, Inc. and reincorporated under the laws of Delaware in June 2000. The Company is a clinical diagnostic company into field of personalized diagnostics based on nuclear magnetic resonance technology. The Company's first diagnostic test, the NMR LipoProfile test, is cleared by the U.S. Food and Drug Administration, and directly measures the number of low density lipoprotein, particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company's technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and, potentially, small molecule metabolites. NMR detectors, or spectrometers, analyze a blood plasma or serum sample by subjecting it to a short pulse of radio frequency energy within a strong magnetic field. The Company currently markets NMR LipoProfile test through a direct sales force in 27 states. The Company competes against companies that offer other methods for measuring lipoproteins. Its competitors include Quest Diagnostics, Berkeley HeartLab, Inc., Atherotech, Inc. and SpectraCell Laboratories. The Company is subject to extensive and frequently changing federal, state and local laws and regulations governing various aspects of its business.

LipoScience (FRA:LI0) Headlines

No Headlines